tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

DYN Stock Latest News

Dyne Therapeutics receives EMA orphan drug designation for DYNE-251
The FlyDyne Therapeutics receives EMA orphan drug designation for DYNE-251
4h ago
DYN
RBC sees Makary interview as potentially positive for biotech stocks
PremiumThe Fly
RBC sees Makary interview as potentially positive for biotech stocks
3d ago
DYN
RNA
Dyne Therapeutics appoints Ranade as CBO, Batra as CSO
PremiumThe Fly
Dyne Therapeutics appoints Ranade as CBO, Batra as CSO
9d ago
DYN
Biotech stocks slide as Marks resignation seen being negative for sector
PremiumThe Fly
Biotech stocks slide as Marks resignation seen being negative for sector
24d ago
DYN
MGX
Marks resignation ‘not good’ for biotech sector, says RBC
PremiumThe Fly
Marks resignation ‘not good’ for biotech sector, says RBC
24d ago
DYN
RNA
Dyne Therapeutics Appoints Erick Lucera as CFO
PremiumCompany AnnouncementsDyne Therapeutics Appoints Erick Lucera as CFO
1M ago
8K
DYN
Dyne Therapeutics appoints Erick Lucera as CFO
Premium
The Fly
Dyne Therapeutics appoints Erick Lucera as CFO
1M ago
DYN
EDIT
Patient Fatality Forces Reality Check on Sarepta Therapeutics Stock (SRPT)
Premium
Market News
Patient Fatality Forces Reality Check on Sarepta Therapeutics Stock (SRPT)
1M ago
DYN
NVS
Buy Rating Affirmed for Dyne Therapeutics Amid Promising DYNE-251 Data and Strategic Milestones
PremiumRatings
Buy Rating Affirmed for Dyne Therapeutics Amid Promising DYNE-251 Data and Strategic Milestones
1M ago
DYN
Promising Advancements and Strategic Positioning of Dyne Therapeutics’ DYNE-251: A Buy Rating Analysis
PremiumRatings
Promising Advancements and Strategic Positioning of Dyne Therapeutics’ DYNE-251: A Buy Rating Analysis
1M ago
DYN
Dyne announces new long-term data from Phase 1/2 DELIVER trial of DYNE-251
PremiumThe Fly
Dyne announces new long-term data from Phase 1/2 DELIVER trial of DYNE-251
1M ago
DYN
Dyne Therapeutics: Innovative Approaches and Promising Clinical Programs Drive Buy Rating
PremiumRatings
Dyne Therapeutics: Innovative Approaches and Promising Clinical Programs Drive Buy Rating
1M ago
DYN
Dyne Therapeutics initiated with an Outperform at BMO Capital
PremiumThe FlyDyne Therapeutics initiated with an Outperform at BMO Capital
1M ago
DYN
Tesla upgraded, Coinbase initiated: Wall Street’s top analyst calls
Premium
The Fly
Tesla upgraded, Coinbase initiated: Wall Street’s top analyst calls
2M ago
W
AL
Dyne Therapeutics initiated with an Outperform at Scotiabank
Premium
The Fly
Dyne Therapeutics initiated with an Outperform at Scotiabank
2M ago
DYN
Dyne Therapeutics price target lowered to $48 from $53 at Piper Sandler
PremiumThe Fly
Dyne Therapeutics price target lowered to $48 from $53 at Piper Sandler
2M ago
DYN
Buy Rating for Dyne Therapeutics: Promising Accelerated Approval Potential for DYNE-101 and DYNE-251
PremiumRatings
Buy Rating for Dyne Therapeutics: Promising Accelerated Approval Potential for DYNE-101 and DYNE-251
2M ago
DYN
Dyne Therapeutics price target lowered to $46 from $55 at H.C. Wainwright
PremiumThe Fly
Dyne Therapeutics price target lowered to $46 from $55 at H.C. Wainwright
2M ago
DYN
Dyne Therapeutics Advances Clinical Programs Amid Financial Losses
PremiumCompany Announcements
Dyne Therapeutics Advances Clinical Programs Amid Financial Losses
2M ago
DYN
Dyne Therapeutics reports Q4 EPS (88c), consensus (91c)
PremiumThe FlyDyne Therapeutics reports Q4 EPS (88c), consensus (91c)
2M ago
DYN
Dyne Therapeutics receives FDA Fast Track designation for DYNE-101
Premium
The Fly
Dyne Therapeutics receives FDA Fast Track designation for DYNE-101
3M ago
DYN
Venu Sports JV discontinued, Walgreens reports Q1 beat: Morning Buzz
Premium
The Fly
Venu Sports JV discontinued, Walgreens reports Q1 beat: Morning Buzz
3M ago
GS
MS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >